05:16 PM EDT, 06/17/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on June 17, 2024, sold 22,500 shares in Cytokinetics ( CYTK ) for $1,183,391. Following the Form 4 filing with the SEC, Blum has control over a total of 420,811 shares of the company, with 416,645 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224018855/xslF345X03/form4.xml